Commercialising Cell and Gene Therapies: From Idea to Patient Impact

Join us for a free, dynamic, interactive event bringing together the people, expertise and perspectives that drive the translation of cell and gene therapy innovations from bench to bedside. This half‑day event marks the launch of the Academy of Medical Sciences’ North of England Cross‑Sector Hub, hosted by the Northern Health Science Alliance (NHSA), creating a new regional focal point for collaboration across academia, the NHS, industry, patient involvement and other key stakeholders.

Our cross-sector networking event aims to:

• Promote inclusive networking across career stages and sectors.
• Support translational readiness and commercialisation understanding.
• Showcase northern strengths across the commercialisation pathway for cell and gene therapies.
• Stimulate new opportunities for collaboration, mentorship, and successful applications to Academy and other funding opportunities.

Discussions exploring pressing cell and gene therapy challenges, include:

• What successful cell and gene therapy translation really requires
• The journey to successful commercialisation for patient benefit
• How the northern ecosystem can support researchers and clinicians

This event is ideal for:

• Early Career Researchers (academia and industry)
• Researchers across all academic career stages
• Academy of Medical Sciences Fellows
• Clinical and NHS colleagues
• Cell and gene therapy industry partners
• Patient advocates and public contributors
• Third sector organisations and innovation ecosystem partners

Info: Speakers:

Hannah Davies, Chief Executive Officer, Northern Health Science Alliance

Rosalind Campion, Chief Executive Officer, Academy of Medical Sciences

Info: Speaker: Professor Mimoun Azzouz​, Chair of Translational Neuroscience, University of Sheffield and Co-founder, BlackfinBio and Crucible Therapeutics

Info: How the North of England ecosystem can support your commercialisation journey

- Intro: Regenerative Cell Therapy Consulting (Regen CTC) - Dr. Zoe Hewitt, Co-Founder and CEO 
- Newcastle Advanced Therapies  - Dr. Mark Jarvis, Director of Newcastle Advanced Therapies 
- Gene Therapy Innovation and Manufacturing Centre (GTIMC), Sheffield – Dr. Joe Cartwright, Head of Projects  
- National Horizons Centre, Teesside - Prof. Safwan Akram, Professor of Biomanufacturing, Engineering Biology and Innovation in Biosciences 
- Advanced Therapy Treatment Centres (ATTC) network and iMATCH, Manchester - Prof. Fiona Thistlethwaite, Director, Innovate Manchester Advanced Therapy Centre Hub (iMATCH) 

Info: Panel moderator: Dr. Zoe Hewitt, Co-Founder and CEO, Regen CTC 

Panellists as above, plus additional panellists TBC

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher The Northern Health Science Alliance